December #192 : TB Preventative Therapy Lowers Deaths by One Third - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Features

The POZ 100: Celebrating Unsung Heroes

The POZ 100: A-C

The POZ 100: D-F

The POZ 100: G-H

The POZ 100: J-L

The POZ 100: M-O

The POZ 100: P-R

The POZ 100: S-T

The POZ 100: V-Z

Positive Networks

From the Editor

Your Song

Feedback

Letters-December 2013

The POZ Q+A

Fire in the Blood

POZ Planet

Law of Desire

Do Some Men Want to Get AIDS?

Rocky Road

Public Knowledge

First in the Fight

Remembrance of Things Past

That ’80s Show

Say What? Lee Daniels Edition

Voices

Remembering J.C. Suares

Care and Treatment

Now Available: New Integrase Inhibitor

‘Quad’ as Effective as Older Options, Fewer Side Effects

Does HIV Make Addiction More Insidious?

TB Preventative Therapy Lowers Deaths by One Third

FDA OKs First Rapid Test for Acute HIV

GMHC Treatment Issues December 2013

Research Notes

Prevention: Malaria Vaccine Shows Promise

Treatment: Soybean Compound May Fight HIV

Cure: Drug-Free Viral Control in Monkeys

Concerns: Lymphoma Survival Unimproved

POZ Survey Says

Your Voice

POZ Heroes

A Mother’s Love

   
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

December 2013

TB Preventative Therapy Lowers Deaths by One Third

by Benjamin Ryan

A six-month course of isoniazid preventive therapy (IPT) for tuberculosis greatly reduces the risk that people with HIV will progress from latent to active TB or die of the disease. TB is the leading cause of death among HIV-positive people in developing nations with the highest rates of HIV.

Researchers screened 7,361 HIV-positive Brazilians and found that 1,455, or 20 percent, were positive for TB infection but did not have any symptoms of the disease, qualifying them to begin taking the daily oral regimen of IPT for six months. To allow for a control comparison period, the study arranged so that every two months two of each of the 29 participating clinics would begin all their participants on therapy at once. The four-year study saw 838 deaths; 475 people developed active TB.

The investigators found that IPT lowered TB deaths and new cases of active TB disease by 31 percent; alone, new cases of active TB dropped by 27 percent.
Jonathan E. Golub, PhD, an associate professor at Johns Hopkins Medicine and one of the study’s co-authors, says IPT is “a relatively simple intervention to give, especially because it’s already recommended to be done in Brazil.”

Search: tuberculosis, TB, prevention, therapy

Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    andais
    Red House
    West Virginia


    romanticseattle
    Tacoma
    Washington


    Heartland4now
    Tacoma
    Washington


    RayOctober
    Richmond
    Virginia
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.